Clinical Trial Update: A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MORF-057 in adults with moderately to severely active Crohn's disease is currently recruiting, sponsored by Morphic Therapeu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• MORF 057

Snippet

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | Conditions: Inflammatory Bowel Diseases, Crohn's Disease | Phase 2 | Status: RECRUITING